Intense uptake of technetium-99m-MDP in primary breast adenocarcinoma with sarcomatoid metaplasia

Journal of Nuclear Medicine

Volumn 38, Issue 4, 1997, Pages 528-530

  Pickhardt, Perry J ^a   McDermott, Michael ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

bone scintigraphy; breast carcinoma; sarcomatoid carcinoma; technetium 99m MDP

Indexed keywords

MEDRONATE TECHNETIUM TC 99M;

ADULT; ARTICLE; BREAST ADENOCARCINOMA; CASE REPORT; CELL DIFFERENTIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; ISOTOPE LABELING; MAMMOGRAPHY; PRIORITY JOURNAL; RADIOISOTOPE DISTRIBUTION; SARCOMA; SOFT TISSUE TUMOR;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; METAPLASIA; MIDDLE AGED; OSSIFICATION, HETEROTOPIC; SARCOMA; TECHNETIUM TC 99M MEDRONATE;

EID: 0030980633     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Bane BL, Evans HL, Ro JY, et al. Extraskeletal osteosarcoma. Cancer 1990:65:2762-2770.
2. Kransdorf MJ. Meis JM. Extraskeletal osseous and cartilaginous tumors of the extremities. Radiographies 1993:13:853-884.
3. Peller PJ. Ho VB, Kransdorf MJ. Extraskeletal technetium-99m-MDP uptake: a pathophysiologic approach. Radiographies 1993:13:715-734.
4. Low-Beer BVA, Bell HG, McCorkle HJ, et al. Measurement of radioactive phosphorus in breast tumors in situ: a possible diagnostic procedure. Radiology 1946;47:492 -493.
5. Whitley JE, Witcofski RL, Bolliger TT, et al. Technetium-99m in the visualization of neoplasms outside the brain. Am J Roentgenol Radium Ther Nuklearmedizin 1966:96: 706-710.
6. Berg GR, Kalisher L, Osmond JD, Pendergrass HP. Potsaid MS. Tcchnetium-99m diphosphonate concentration in primary breast carcinoma. Radîology 1973:109:393-394.
7. Ross McDougall t. Pistenma DA. C'oncentration of technetium-99ni diphoshonate in breast tissue. Radiology 1974:112:655-657.
8. Hobbs S, Neumann RD, Merino MJ. Gunzenhauser J, Carascquillo JA. Localization of technetium-99m-MDP in cystosarcoma phyllodes. Clin Nuel Meet 1992; 17:58-60.
9. Serafmi AN, Raskin MM, Zard LC, Watson DD. Radionuclide breast scanning in carcinoma of the breast. J Nucl Med 1974;15:1149 -1152.
10. Piccolo S, Lastoria S, Mainolfi C, Muto P. Bazzicalupo L, Salvatore M. Techneiium99m-MDP scintamammography to image primary breast cancer. J Nucl Med 1995;36: 718-724.
11. Waxman AD. Ramanna L, Memsic LD, et ai. Thallium scintigraphy in the e\alu;.tion of mass abnormalities of the breast. J Nucl Med 1993:34:18-23.
12. Lee VW, Sax EJ. McAneny DB, et al. A complementary role tor thallium-201 scintigraphy with mammography in the diagnosis of breast cancer. J Nucl Weil 1993:34:2095-2100.
13. Waxman AD, Ashok G. Kooba A, et al. The use of technetium-99m-MlBI in evaluation of patients with primary carcinoma of the breast: comparison A'ith thallium-201 [Abstract]..J Nucl Med 1993;34:(suppl):139P.
14. Khalkhali I, Cutrone JA. Mena IG, et al. Scintimammography: the complementary role of technetium-99m sestamibi prone breast imaging for the diagnosis of breast career. Radiology 1995:196:421-426.
15. Waxman A, Nagaraj N, Ashok G, et al. Sensitivity and specificity of technetium-9-)mMIB1 in the evaluation of primary carcinoma of the breast [Abstract]. J Nucl Med 1994:35:(suppl).22
16. Lastoria S, Varrella P, Mainolfi C, et al. Technetium-99m sestamibi scintigraphy in the diagnosis of primary breast cancer [Abstract]. J Nucl MeJ 1994;35:(supp!):22P.
17. Foschini MP, Dina RE, Eusebi V. Sarcomatoid neoplasms of the breast: propcsed definitions for biphasic and monophasic sarcomatoid mammary carcinomas. Senzn Diag Path 1993:10:128-136.
18. Wargot? ES. Norris HJ. Metaplastic carcinoma of the breast. I. Matrix-producing carcinomas. Human Path 1989:20:628-635.
19. Burnett KR, Lyons KP. Theron-Brown W. Uptake of ostcotropic radionuclides in the breast. Semin Nucl Med 1984:14:48- 49.
20. Worsley DF. Lentle BC. Uptake of technetium-99m-MDP in primary amyloidosis v ith a review of the mechanisms of soft-tissue localization of bone-seeking radiophannaceuttcals. J Nucl Med 1993:34:1612- 1615.